Digital health case studyPharmaceutical
Pinpointing Oncology Ventures with Clinical Trial Capability in Emerging Markets
Client context: Large global pharmaceutical
Strategic question
Which oncology ventures in emerging markets can offer advice, patient cohorts or clinical trial capability at scale?
Approach
Combining HealthTech Alpha with structured ecosystem mapping, we evaluated 113 oncology-focused ventures across eight markets and built a highly prioritised target list aligned to clinical trial and cohort criteria.
Strategic implication
Reframed emerging markets as credible clinical execution partners rather than peripheral geographies, and surfaced the specific ventures with partnership potential.
